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Background: Asthma is a prevalent disease that is considered a health problem worldwide. The aim of this study
was to analyze the clinical and socioeconomic characteristics of a cohort of asthmatics receiving specialized
outpatient treatment in a tertiary/teaching public hospital in Brazil.
Methods: Persistent asthmatics older than 5 years old were consecutively included. They received clinical treatment
at 3- to 4-month intervals and were interviewed 2 times at 6-month intervals over a 12-month observation period.
The data were collected directly from the patients or their parents by 2 researchers who did not participate in their
clinical care. The primary variables were age, gender, education level, monthly family income, place of residence,
number of lost days of school or work, BMI, the severity and control level of asthma, the number of scheduled and
non-scheduled visits and hospitalization days and the best peak-flow measurement.
Results: Of the 117 participants, 108 completed the study. Of the participants, 73.8% were women, and 25.0% lived
outside the county. Of those who lived within the county, 60.1% lived in areas far from the health care unit. The
majority (83.3%) had associated rhinitis, and more than 50.0% were overweight or obese, in whom the prevalence
of severe asthma was greater (p = 0.001). The median monthly income was US$ 536.58 and was greater among the
patients with controlled asthma (p = 0.005 and p = 0.01 at the start and the end of the study, respectively). In the
initial evaluation, 16 participants had severe asthma, and in the final evaluation, 8 out of 21 patients with
uncontrolled asthma had improved. Three-quarters of the students and half of the workers had missed days of
school or work, respectively. The asthmatic population in this study had medium to low socioeconomic status in
Brazil and socioeconomic status was associated with overweigth/obesity and with poor control of asthma.
Conclusion: Asthma has a great impact on absenteeism in Brazil. Lower monthly family income and body weight
above the ideal level were associated with greater severity and worse control of asthma.
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Asthma is one of the most prevalent chronic diseases in
the world and is considered a public health problem
worldwide [1,2]. The prevalence of asthma in developed
countries increased 50% per decade in the last 40 years
of the 20th century, and approximately 250,000 deaths
occur worldwide because of asthma each year [1].
Asthma is often associated with chronic rhinitis, which
can be allergic or not. Studies indicate that 75% to 80% of
the individuals with asthma have allergic rhinitis, and
40% to 50% of the individuals with allergic rhinitis and
eosinophilic non-allergic rhinitis have bronchial hyperre-
sponsiveness (BHR) [2-4]. Conservative estimates suggest
that 500 million people have allergic rhinitis and 300* Correspondence: educostamd@gmail.com; rrufino.uerj@gmail.com
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reproduction in any medium, provided the ormillion people have asthma around the world [2-4]. The
Pan American Health Organization (PAHO) estimates
that there are approximately 15 million asthmatics in
Brazil [5].
In Brazil, the data from the International Study of
Asthma and Allergies in Childhood (ISAAC), conducted
in various capital cities, showed that the average preva-
lence rates of allergic rhinitis were 12.6% and 14.6% in
children and adolescents, respectively, and the respective
prevalence rates of active asthma were 24.3% and 19% [6].
The ISAAC data obtained in cities in the state of Rio de
Janeiro showed that the prevalence of active asthma var-
ied from 13-17% in adolescents [7,8]. There are no recent
data on the prevalence rates of rhinitis and asthma in the
adult Brazilian population. It is estimated that rhinitis
affects 20% or more of the general Brazilian population
and asthma may affect up to 10%, which means that 19 totd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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number of hospitalizations due to asthma in the Brazilian
public health system decreased between 2000 and 2011, it
remains one of the main causes of hospitalization and
imposes a large social and economic burden on the
country [9]. Comparing population-based data on adults
in Southern Brazil from 2000 to 2010, Fiori and collabora-
tors found that the prevalence rates of asthma were 4.2%
and 5.2%, respectively [10].
The Brazilian health system executes the principles
defined in the Brazilian Constitution of 1988, which
characterized health as a “citizenship right and a duty of
the State”. According to the guidelines defined by Law
no. 8080/1990 [11], the health system is characterized by
universal access and a regional hierarchy of services.
Although there have been several programs to organize
asthma care at different levels of complexity in the
Unified Health System [Sistema Único de Saúde – SUS],
even large urban centers have not been able to guarantee
access for the entire population to the most appropriate
level of treatment for the severity of their disease. This
obstacle prevents optimal control of asthma and thus
prevents reducing its associated morbidity and mortality.
Broad knowledge on the various aspects of chronic
diseases, including their clinical and socio-demographic
characteristics and the care-seeking behavior of the indi-
viduals affected who require health services at different
levels of complexity, can optimize the allocation of re-
sources for primary, secondary and tertiary prevention
in the Brazilian health system.
The objective of this study was to describe the charac-
teristics of a cohort of patients with persistent asthma
who sought specialized treatment in a secondary/tertiary
ambulatory care center linked to a university hospital in
a large city in Brazil. We analyzed socio-demographic
and clinical variables as potential indicators of patient
care-seeking behavior at the local health care facilities.
Methods
Patients older than 5 years of age with a diagnosis of per-
sistent asthma based on previously established consensus
criteria [2,9] and who had been receiving treatment for
at least 3 months in a specialized ambulatory care
center (Allergy-Immunology and Pneumology-Phthisiology
Services) in a university hospital in Rio de Janeiro city
were consecutively enrolled in the study from April to
September 2011. In both services, ambulatory care is pre-
dominantly performed by physicians in a residency pro-
gram. In 2011, 326 patients with asthma were monitored
in these services. All of the patients underwent routine
visits at 3- to 4-month intervals and were interviewed twice
during this period after a 6-month interval. All interviews
were taken in the same day of a scheduled clinical visit.
The last interview was performed in March 2012. The datawere collected using a tool developed by the authors,
which was pre-tested with 30 patients before the begin-
ning of the study. Two interviewers (the first and second
authors of the present study) who did not participate in
the clinical care of the patients received training and
performed the data collection on both occasions. In
interviews with individuals younger than 18 years of age,
all of the questions were answered by a responsible adult,
and individuals older than 14 years of age offered supple-
mentary answers when necessary.
The following variables were collected:
– socio-demographic variables: age, gender, education
level, monthly family income, the neighborhood
where the patients were residing on the day of the
interview and the number of days the patient was
absent from school or work in the 3 months
preceding the interview (to avoid recall bias);
– clinical variables: BMI on the day of the interview,
the severity and control of the patient’s asthma in
the month preceding the interview, the number of
scheduled appointments the patient attended and
the number of days of hospitalization in the
6 months preceding the interview and the number
of unscheduled/emergency visits in the 3 months
preceding the interview (to avoid recall bias);
– functional variable: the highest of 3 peak expiratory
flow (PEF) readings on the day of the interview.
The severity (intermittent, mild persistent, moderate
persistent and severe persistent) and the control of the
patient’s asthma (controlled, partially controlled and un-
controlled) were assessed by the attending physician at
the time of the interview using clinical data from the
past 4 weeks in accordance with international guidelines
[2,9]. The treatment regimen was only changed during
the study by the attending physician if a change was in-
dicated according to the same guidelines [2,9]; the inter-
viewers who collected the data after the medical care
was provided had no influence.
Overweight and obesity were defined as BMI ≥ 25 and
BMI ≥ 30, respectively, for individuals older than 18 years
and as weight-for-the age > Z score + 1 SD and weight-
for-age > Z score + 2 SD, respectively, for those less than
18 years of age [12]. Annual estimative of school and
work losses, as well of unscheduled/emergency visits had
made by doubling results of these variables, because they
were collected regarding the three previous months.
The patients who dropped out of treatment (i.e., had
no return visits for > 4 months) and the patients with
chronic cardiopulmonary disease that could cause re-
spiratory symptoms similar to asthma and influence the
use of treatment resources were excluded from the study.
Before the data collection, the patients (or the guardians
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formed consent form after being informed about the study.
The study was approved by the local Research Ethics
Committee (REC). The project was registered with the
Brazilian National Research Ethics Committee [Comissão
Nacional de Ética em Pesquisa - CONEP] under number
FR413262 and approved by the local REC on 05/03/2011.
All of the data were entered in spreadsheets (MS
Office/Excel 2010, Microsoft Co., CA, USA) by the first
author of the present study. GraphPad Prism version 6.0
(GraphPad Software Inc., La Jolla, CA, USA) was used
for statistical analysis. The chi-square test (with Fisher’s
correction when necessary) and the Mann–Whitney test
were used to compare the differences between categor-
ical variables and the differences between continuous
unpaired variables, respectively. The paired t-test and
Wilcoxon’s test were used to compare continuous paired
variables. A significance level of 5% was used.
Results and discussion
During the study period, 117 patients were enrolled. Nine
patients did not complete the study (7.7% loss): 1 patient
died of a cause unrelated to asthma, 1 patient asked to be
discharged and 7 patients dropped out of treatment be-
fore the second interview. The final study population
(108 patients, representing 33.12% of the asthmatic pa-
tients in treatment in the two Services) included 80 pa-
tients who were followed at the Allergy/Immunology
Service and 28 patients from the Pneumology Service. Of
the participants, 79 were women (73.8%) and 29 were
men (27.1%). This female gender predominance wasTable 1 General characteristics of the patients
Source – N (%) Allergy-Im
Pneu
Gender – N (%) M
Fe





Residence – N (%) Rio de J
Rio de Janeiro city
> 10 km from th
Othe
Age (years) Median (pe
Duration of asthma (years) Median (pe
Duration of rhinitis (years) Median (pe
Monthly family income (U$) Median (pe
Peak flow meter Median (percabsent among patients under 20 years-old. Most of the
patients (75.0%) resided in Rio de Janeiro city; however,
60.1% of these residents lived in remote areas (defined as
more than 10 km distant from the health care unit).
The median monthly family income was R$ 1,100.00
(equivalent to US$ 536.58; IQR25-75 = 348.78-975.61),
which falls into the economic classes C1 and C2 [13],
considered the lowest stratum of medium economic class in
Brazil. Among our patients the primary education level pre-
dominates (n = 76/70.4%), 25 (23.1%) have secondary level
and only 7 (6.5%) have tertiary or post-graduate educational
level, with median monthly family income of US$ 487.80
(IQR 25–75 = 290.24-709.76), US$ 780.49 (IQR 25–75 =
414.63-975.61) and US$ 1,365.85 (IQR 25–75 = 1268.29-
1951.22), respectively. Distributions and medians of gender,
local of residence, occupational status, educational level,
age, duration of asthma and of rhinitis, peak-flow measure-
ments and monthly income are shown in Table 1.
Ninety patients (83.3%) had chronic rhinitis associated
with asthma. The proportion of asthma cases associated
with rhinitis was higher among the patients from the
Allergy-Immunology Service (p = 0.0001), whereas the
patients from the Pneumology Service were older, had
asthma for a longer duration, experienced more severe
asthma and had a greater prevalence of overweight/obes-
ity (p = 0.02, p = 0.04, p = 0.01 and p = 0.01, respectively).
Sixty-seven patients (62.0% of the total) had another
medical comorbidity: 41 out of them (61.2% of patients
with comorbidities) had systemic arterial hypertension
(SAH), none were using beta-blockers, 11 (16.4%) had









aneiro city 81 (75.00)
but in remote areas 65 (60.19)
e health care units
r cities 27 (25.00)
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rcentile 25-75) 18.00 (9.50 – 33.00)
rcentile 25-75) 19.00 (8.00 – 30.75)
rcentile 25-75) 558.13 (356.97 – 930.23)
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cluded thyroid disease, depression, dyslipidemia and
gastro-esophageal reflux. Table 2 shows distribution of
gender, monthly family income, weight status and
presence of self-referred comorbidities by age ranges.
Of the patients whose body weight was above the healthy
weight range (n = 64 / 59.2% of the total), 35 (32.4%) were
overweight and 29 (26.8%) were obese. None of children
and teenagers were obese and only 2 (9.5%) were over-
weight, while obesity and overweight predominated among
other age ranges (Table 2). The proportion of severe
asthmatics was greater than the proportion of mild/
moderate asthmatics among the overweight/obese patients
compared with the normal weight patients in the start of
study (p = 0.001). This difference persisted when we ana-
lyzed only women, who represented the majority of the
population (p = 0.01) (Figure 1).
At the beginning of the study, 53 patients (49.08%) were
classified as having mild asthma, 39 (36.11%) had moder-
ate asthma and 16 (14.81%) had severe asthma. By the
final evaluation, the classification of 42 patients (38.90%)
had changed to intermittent asthma, and 8 (38.09%) of the
21 patients who initially had uncontrolled asthma demon-
strating the intra-individual variability of the disease and
improvements in their control after 6 months of treat-
ment. The average PEF measurements increased signifi-
cantly during the study (p < 0.0001), and the changes in
severity were statistically significant (p < 0.0001) (Figure 2).
Futhermore, 12 patients (11.11%) were not taking medica-
tion to control their asthma, whereas only 4 patients
(3.7%) were not taking it at the time of the second data
collection (2 with intermittent/controlled asthma and 2
with moderate persistent asthma; 1 partially controlled
and 1 uncontrolled).Table 2 Gender, family income, weight status and self-referre
Characteristics b
Age range(years) Gender N (%) Monthly income (US$)
Median (IQR25-75)
< 20 Male = 12 (57) 439.02
Total=21 Female = 09 (43) (292.68-731.70)
20 – 39 Male = 03 (17.7) 975.61
Total=17 Female = 14 (82.3) (414.64-1,317.07)
40 – 59 Male = 08 (18.2) 536.58
Total=44 Female = 36 (81,8) (382.97-975.61)
> 60 Male = 05 (19.2) 534.14
Total=26 Female = 21 (80.8) (270.14-780.48)The patients attended 444 appointments in the
6-month period before the first interview and 330 ap-
pointments in the 6-month period before the second
interview (mean 4.11 and 3.05 visits/patient/semester,
respectively). There were 108 visits without an appoint-
ment (ambulatory care or urgent care/emergency) in the
3 months prior to the first interview and 49 in the
3 months prior to the second interview (mean 1.00 and
0.45 visits/patient/trimester, respectively). The median
expenditure with public or private transport to attend
these visits was US$ 9.76 per patient (IQR25-75 = 5.37-
14.63). Only one and two patients went to visits by foot
in the first and second interviews/clinical visits, respect-
ively. In the 6 months preceding the first data collection,
3 patients were hospitalized due to asthma (total of
13 days of hospitalization; mean 4.33 days/patient), and
2 patients (total of 7 days of hospitalization; mean
3.5 days/patient) were hospitalized within the 6 months
preceding the second data collection.
Monthly family income was lower among the patients
with uncontrolled asthma both at the beginning and at
the end of the study (p = 0.005 and p = 0.01, respectively;
Figure 3). At the beginning of the study, the patients with
uncontrolled asthma had a median monthly income of
U$ 372.09 (25–75 percentile = U$251.16 – U$534. 88),
whereas those with controlled asthma had higher in-
comes (median = U$ 558.13; 25–75 percentile = U$
390.69 – U$ 1,162.69). At the end of the study, this dif-
ference persisted (uncontrolled asthma: median = U$
372.09 versus controlled asthma: median = U$ 604.65).
Regarding severity in the two points of observation, the
mean annual family income of patients with severe, mod-
erate, mild and intermittent asthma was U$ 8,115.06, U$
8,327.64, U$ 10,409.82 and U$ 9,563.76, respectively.d comorbidities distribution by age ranges
y age ranges
Weight status N (%) Self-referredco-morbidities N (%)
Obese = 0 (0.0) Yes = 06 (28.5)
Overweight = 02 (9.5) No = 15 (71.5)
Normal = 19 (90.5)
Obese = 06 (35.3) Yes = 08 (47.0)
Overweight = 06 (35.3) No = 09 (53.0)
Normal = 05 (29.4)
Obese = 14 (31.8) Yes = 31 (70.5)
Overweight = 16 (36.4) No = 13 (29.5)
Normal = 14 (31.8)
Obese = 9 (34.6) Yes = 22 (84.6)
Overweight = 11 (42.3) No = 04 (0.0)
Normal = 06 (23,1)
Figure 1 Weight and asthma severity in first evaluation: (A) in whole population; (B) in women.
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mean family incomes during the study, whereas mild
asthmatics did not. Estimative of annual costs of asthma
treatment per patient showed that severe ones expend
12% of family annual income, whereas the moderate
asthmatics expend 4.8%, mild patients 3.6% and intermit-
tent ones 3.7% of annual income treating their asthma.
None of the 53 patients with controlled asthma were
smokers, but 3 patients with partially controlled or un-
controlled disease were still smoking. Three other pa-
tients whom live together with smokers had their
asthma each one controlled, partially controlled and not
controlled.
At the end of data collection, the difference between
asthma control of the patients in the Allergy/Immun-
ology Service compared with patients in the Pneumology
Service didn’t reach statistical significance at 5% level
(p = 0.08), however we don’t know if it would be differ-
ent with a greater sample. Of the patients treated at the
Pneumology Service (who had more severe asthma and
a high prevalence of overweight/obesity), the proportion
of patients with partially controlled or uncontrolledFigure 2 Evolution of asthma severity during the study.asthma was higher among the overweight/obese patients
compared with those of normal weight (p = 0.001;
Figure 4). There were no differences in gender distribu-
tion (p = 0.62) or the monthly family income (p = 0.39)
between patients from the two Services.
Eighteen (75.0%) of the 24 students missed school be-
cause of asthma, and 13 patients missed work because
of their illness (38.3% of employees outside home). In-
cluding the 4 employees who were absent from work to
take care of their children with asthma, a total of 17
employees (51.5% of the individuals working outside
the home) missed work because of asthma in the
3-month periods prior to each interview. The partici-
pants missed an estimated total of 163 school days/year
and 164 working days/year, or an average of 6.79 days/
student/year and 9.64 days/employee/year.
In the first assessment, 4 patients were not working
and collecting sickness benefits, including 1 with severe
uncontrolled asthma and 3 patients with moderate
disease. In the second evaluation, 2 of these patients had
retired because of disability related to their asthma, one
remained out of work, another one lost her job, and
another patient (with partially controlled moderate per-
sistent asthma) had also stopped working and was col-
lecting sickness benefits.
Few published studies with different main objectives
have described the profile of asthmatic patients receiving
specialized monitoring in medium to high complexity
hospitals. It is estimated in published guidelines that
60.0% of asthma cases are intermittent or mild persistent,
25.0% to 30.0% are moderate, and only 5.0% to 10.0% are
severe [2,9]. This minority of severe asthmatics utilizes the
most costly resources (e.g., medication, non-scheduled
ambulatory visits, emergency visits and hospitalizations)
and account for most of the mortality caused by the
disease. These patients usually have the worst asthma con-
trol and are most in need of monitoring at secondary and
tertiary heath care facilities [2,9,14].
Figure 3 Month family income and asthma control: (A) initial evaluation; (B) Final evaluation (median / percent 25–75 / minimum
and maximum).
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nearly 15.0% of the patients had severe asthma, which
was higher than the estimated proportion for the general
population of asthmatics but still small for a specia-
lized ambulatory care center in a moderate- to high-
complexity unit. We observed a large proportion of
patients with mild asthma in this population. In part,
this result may be related to the large number of patients
followed in Allergy/Immunology Services, where allergic
asthma is predominant and the proportion of patients
with more severe disease is lower than the proportion of
adult patients with non-allergic asthma. Part of the
demand from patients with less severe disease could be
absorbed by units in the basic health care network if all
or most of the local network had health care teams
properly prepared to address the disease. Asthma care
programs already exist in other regions of the country,
which may be one of the reasons why fewer patients are
admitted with moderate/severe asthma that requires spe-
cialized assistance with more diagnostic and therapeutic
resources.
In a study with 90 participants that compared the
direct costs of treating patients with controlled andFigure 4 Weight and asthma control among Pulmonology
Section’s patients.uncontrolled asthma (45 per group) in a Brazilian ter-
tiary health care unit, the mean age was similar to the
age of our population, but the average monthly family
income was lower [15]. Thirty-one patients had mild
asthma (34.4%), 41 had moderate asthma (45.5%), and
18 (20.0%) had severe asthma: compared with our popu-
lation, a slightly higher proportion of patients had severe
asthma and a slightly lower proportion had mild asthma
in that unit. Even so, we still consider the percentage of
patients with mild asthma treated in a university hospital
in the largest Brazilian city to be high, suggesting that
the city experiences difficulties similar to ours in distrib-
uting the demand from asthmatic patients across the
hierarchy of public health care units.
The data from the second evaluation of our patients
show that a large proportion of the patients were able to
control and/or reduce the severity of their asthma after
6 months. Some of these patients should be referred to
less complex units close to their homes, providing
greater comfort to the patients and opening up spaces to
admit and treat patients with more severe disease. This
issue reflects the difficulties in referring patients between
the health care units of varying complexity in the health
care system.
Approximately 10.0% of the patients did not achieve
total or partial control of the disease, even while
undergoing treatment in a university hospital where,
theoretically, more comprehensive approaches are ap-
plied in accordance with the latest guidelines and the
access to many diagnostic resources is unrestricted.
Limited access to medications for treatment may have
contributed to this problem because most of the patients
depended on obtaining free samples or buying medica-
tions with their own resources.
A retrospective study performed in a Brazilian univer-
sity reported results similar to ours in terms of the mean
age, the proportion of women and the proportion of
patients with severe asthma among the patients in
treatment [16]. Based on the evaluation of the last
prescription in the records, the use of the pharmaco-
logical treatment in accordance with the guideline
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time was low. Among the patients with persistent
asthma, a large proportion (71.0%) had no prescription
for inhaled corticosteroids. The current guidelines for
asthma management clearly state that continuous use of
inhaled corticosteroids, tailored to the severity level and
control of the disease, is the most effective strategy for
reducing morbidity and mortality from persistent asthma
[2,9]. The cited study, unlike ours, included patients
treated in other services that address asthma but were
not specialized in Allergy or Pulmonology, which may
have contributed to the undesirable result. This study
suggests that even in a university hospital in a large
Brazilian city, teams that do not specialize in respiratory
diseases (pediatricians, internists and general practi-
tioners) are not properly applying the recommended
treatment guidelines for the disease.
Exacerbating the problem of inappropriate prescrip-
tion practices, there are high rates of non-adherence and
inadequate adherence to the treatment regimen (poten-
tially greater than 70%), and the dropout rate from con-
trol medications can reach 92.0% after 1 year [17-19].
Our population has a low to medium socio-economic
profile, with access to urban transport and medication.
Moreover, in our institution, a university health unity, is
admired for most of people and has a good reputation in
the city. These facts can helped us to reach this low level
of losses during the study (only 7 out of 117 allocated
patients dropped out of treatment during the 12 months
of observation).
In another study that retrospectively analyzed 434
asthmatic children and adolescents included in the as-
sistance program in Brazilian primary health care units
between 1988 and 1993 [20], more than 50.0% dropped
out during the monitoring phase, predominantly in the
first 6 months of treatment. Among those who contin-
ued with the monitoring program, the asthma assistance
program in the primary health care unit achieved suc-
cesses in terms of clinical improvement and greater
adherence to drug treatments [21].
In our population of patients with persistent asthma,
11 (10.1%) were not taking continued inhaled corticoster-
oid at the beginning of the study (2 uncontrolled, 5
partially controlled and 4 considered controlled). The
mean monthly income of them was not significantly dif-
ferent from the rest of patients using inhaled corticoste-
roids (US$ 595.61/SD = 355.70 versus US$ 764.39/SD =
746.34; p = 0.21). The proportion of non users of inhaled
corticosteroids dropped to 3.0% (2 patients with uncon-
trolled and partially controlled asthma, each one) of the
66 patients with persistent asthma at the end of the
study. In addition, the number of unscheduled visits to
the ambulatory care unit or emergency care decreased
throughout the study. The study was observational; therewas no active attempt by the researchers to change the
patients’ therapy because they had already been receiving
treatment for at least 3 months when they joined the
study. These data suggest that the local teams are capable
of providing competent care in alignment with the
current recommendations for drug treatment for asthma
[2,9]. We can’t rule out the possibility that patients’
adherence improved when they were informed that they
were participating in a longitudinal study after the first
data collection that would include a second data collec-
tion (Hawthorne effect) and/or that the teams paid more
attention to the medications of the participants between
the two data collection points because the support staff
could identify the patients participating in the study.
Furthermore, asthma severity and asthma control natur-
ally vary over time. The first data were collected in the
fall and winter, whereas the second collection occurred
during the spring and summer, when the weather
contributes to better clinical outcomes of asthma in our
geographic region.
Our results demonstrate that asthma has a strong im-
pact on school and work attendance because 75.0% of the
students missed days of school and 34% of employees
missed days of work directly because their asthma. This
proportion grows to more than 50% if we also consider
adults that missed work to care their children with
asthma. Our prevalence of work absenteeism are clearly
bigger than published results from a cohort of industry
employees aged 16 to 65 years old in Brazil, where the
one year prevalence of work days lost to health problems
was 13.5% [22]. In addition to causing absences from
work when the disease is exacerbated, asthma also causes
long temporary absences. In Brazil in 2008, sickness ben-
efits for asthma were provided to 7.5/100,000 employees
for a median duration of 49 days (IQR 25–75 =
28–87 days) [23]. In a transversal study on health related
work days lost during 30 months among public service
workers in Vitória, a medium seaside city in the same re-
gion of Rio de Janeiro (southwest of Brazil), respiratory
diseases was the first cause of absenteeism with an aver-
age of 8.4 days and median of 5 days lost per period of
license [24]. In the population that we studied, 5 patients
(4.6% of total and 15.1% of employees) with moderate to
severe asthma were out of work during the study period,
2 retired due to disability, and 1 lost a job. The monthly
income of patients with uncontrolled asthma was lower
than the income of those with controlled asthma at both
observation points. Despite the small number of patients
with uncontrolled disease, and considering that only 5
patients (6.6% of all working aged asthmatics) were out
of work or retired due to asthma, our results suggest that
lower income can contribute to worse the disease. How-
ever, the lower mean monthly family incomes of severe
patients compared to moderate and mild ones as well as
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patients during the study, but not in mild ones, suggest
that the disease can also contribute to lower family in-
come reducing the working capacity of patients or their
parents.
As the literature has already described, we noted a fre-
quent association between asthma and chronic rhinitis,
which reinforces the need to devote attention to treatment
that properly controls this comorbidity in asthmatics [3].
In a regional Brazilian program, adults with moderate to
severe asthma were monitored and receive inhaled medi-
cation to control their asthma. For 21 months in 2003 and
2004, 269 patients with a median age of 46 years were
included in a study of the characteristics and costs of
asthma. Rhinitis was present in 72% of the patients, a
lower proportion than what we found despite the greater
severity of asthma in those patients. Less than half of the
patients were working, and the second and third-largest
proportions were composed of unemployed people and
retirees, respectively. The majority (74%) had a monthly
family income less than the national minimum wage (i.e.,
the population was poorer than the one followed in our
study). Nevertheless, with free medication, amelioration of
asthma control and a reduction in hospitalizations were
achieved [25].
Other clinical comorbidities were also common in our
population, especially overweight/obesity and systemic
arterial hypertension, which can impair the control of
asthma or compete for financial resources used for
asthma treatment, respectively. Overweight and obesity
were associated with increased asthma severity in all of
the patients and with worse control of the disease among
the patients with more severe disease, older patients and
patients with a longer duration of asthma. None of the
asthmatic patients with systemic arterial hypertension
were using a beta-blocker, which is known to aggravate
asthma.
Another study conducted by the Bahia State Asthma
and Allergic Rhinitis Control Program (Programa de
Controle da Asma e Rinite Alérgica na Bahia - ProAR) in
Brazil sought to evaluate the factors associated with severe
asthma in the population [26]. Clinical data from 102
asthmatics treated in 2007–2008 were evaluated retro-
spectively. The mean age was 44.0 years (± 13.6). Only
2.9% of the patients had mild asthma, 30.4% had moderate
asthma, and 66.7% had severe asthma, as expected for a
specialty service for asthma. In this population, 61.7% of
the patients were overweight or obese, a proportion simi-
lar to our findings, even though we observed fewer severe
cases. There was also a significant association between
arterial hypertension and asthma.
The increasing prevalence of overweight/obesity in
Western societies has been identified as a factor associ-
ated with the increased prevalence of asthma. Data fromthe USA show that the prevalence rates of asthma and
obesity increased to a similar extent between 1980 and
2000 [27]. Data of Brazilian Health Ministry, obtained by
a telephone surveillance system in 2011 showed that
64.3% of Brazilian adults had overweight or obesity, a
similar result compared with ours, but with a smaller
proportion of obese (15.8%) and more overweight (48,5%)
[28]. Studies have shown that obesity is associated with
an increased risk of asthma symptoms. This association
could initiate in early life, being greater in adults than in
children and in adult women than in men, but the nature
of these potential reciprocal effects still need further
investigation [29]. Obesity appears to contribute to reduce
responsiveness to medication, worsening control and
increasing associated costs of the disease. This could be
due to a change in asthma phenotype, particularly evi-
denced as a less eosinophilic type of airway inflammation
with less responsiveness to inhaled conticosteroids, com-
bined to the added effects of changes in lung mechanics
[30-32].
These results reinforces that, besides providing free
access to control medication, which recently was became
available by Brazilian government, the public health
system needs to make efforts to provide primary health
facilities with interdisciplinary teams prepared to
approach the various educational, socioeconomic and
clinical aspects of asthma and its comorbidities to
medium/lower income population. Focus in drug treat-
ment as defined by international guidelines, continuing
clinical and functional monitoring and adequate ap-
proaching to rhinitis and obesity are needed.
Conclusions
The population of individuals with asthma followed in
this moderate- to high-complexity health care unit had
medium-low socioeconomic status in Brazil, a high preva-
lence of associated chronic rhinitis and a high prevalence
of overweight/obesity. A large proportion of the patients
have missed days of school or work for reasons were dir-
ectly or indirectly related to the disease. Lower monthly
family income and body weight above the ideal level were
associated with greater severity and worse control of
asthma. In Brazil, there are difficulties in building a re-
gional and hierarchical public health system, which may
be the consequence of an inadequate supply of services.
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